1 / 17

USE OF RECOMBINANT ACTIVATED PROTEIN C IN GLASGOW INTENSIVE CARE UNITS

USE OF RECOMBINANT ACTIVATED PROTEIN C IN GLASGOW INTENSIVE CARE UNITS. ALEX PUXTY SpR Glasgow Royal Infirmary. BACKGROUND. SICS guidelines (2003) NICE guidelines (2004) ≥ 2 organ failures excluded APACHE II data. Surviving Sepsis Campaign (2004) included APACHE criteria ≥25. OBJECTIVES.

ulf
Télécharger la présentation

USE OF RECOMBINANT ACTIVATED PROTEIN C IN GLASGOW INTENSIVE CARE UNITS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. USE OF RECOMBINANT ACTIVATED PROTEIN C IN GLASGOW INTENSIVE CARE UNITS ALEX PUXTY SpR Glasgow Royal Infirmary

  2. BACKGROUND • SICS guidelines (2003) • NICE guidelines (2004) ≥ 2 organ failures excluded APACHE II data. • Surviving Sepsis Campaign (2004) included APACHE criteria ≥25

  3. OBJECTIVES • Determine rAPC usage in Glasgow: • Patient characteristics & outcome • Implementation of other “Surviving Sepsis Campaign” recommendations Method: • Retrospective case note review patients received rAPC in Glasgow 1/8/6 - 31/7/7 • Identified from pharmacy records

  4. DEMOGRAPHICS 44 patients across all hospitals Not evenly spread Median organ failures was three

  5. “JOURNEY OF PATIENTS” • Many of these patients straight from A+E • Significant majority within 2 days of admission

  6. “JOURNEY OF PATIENTS” • Guidelines state that should be given within 48hrs • Some would say that other therapies should be tried first

  7. RECEIVING rAPC: ORGAN FAILURES? All met NICE criteria

  8. RECEIVING rAPC: APACHE II? Surviving sepsis guidelines include APACHE II 36% did not meet this criterion

  9. OUTCOME DATA • EXPECTED MORTALITY: 56.05% • ACTUAL MORTALITY 47.7% • SMR: 0.85

  10. SURVIVING SEPSIS CAMPAIGN • Recommendations regarding OTHER MANAGEMENT TARGETS • Audited against 2004 Guideline

  11. CONCLUSION • By NICE guidelines, all patients who received rAPC qualified • Not by surviving sepsis guidelines • Decision on which to follow • Other interventions have varying degrees of success with implementation

  12. AND NOW FOR……A SHAMELESS PLUG!

  13. FURTHER STUDY • Plan to audit if all patients who qualify receive rAPC • Scotland wide • SICSAG sprint audit • Attached questionnaire on attitude towards rAPC

  14. QUESTIONS?

  15. Some Data Difficult To Ascertain If Measured Blood Cultures Before Abx Difficult To Determine Absence Of ScvO2 MISSING DATA

More Related